Key Metrics
CiteScore 

1.6
SJR 

Q4Oncology

SNIP 

0.34
Recommended pre-submission checks
Powered by 

Topics Covered on Experimental Oncology
Experimental Oncology Journal Specifications
| Overview | |
| Publisher | INST EXP PATHOL ONCOL RADIOBIOL |
| Frequency | Quarterly |
| General Details | |
| Frequency | Quarterly |
| Website URL | Visit website |
View less
Planning to publish in Experimental Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Experimental Oncology
Title not available
- 30 Dec 2025
- Experimental Oncology
UTILIZING INFRARED IMAGING TO EVALUATE THE AGGRESSIVENESS OF PROSTATE CANCER.
- 30 Dec 2025
- Experimental oncology
RADIOFREQUENCY ABLATION AS PART OF INTRAHEPATIC TREATMENT STRATEGIES.
- 30 Dec 2025
- Experimental oncology
ASSOCIATION OF INTRON 4 VNTR (4A/B) POLYMORPHISM OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE WITH THE INCIDENCE OF BREAST CANCER IN IRAQI WOMEN.
- 30 Dec 2025
- Experimental oncology
SIMULTANEOUS VS STAGED RESECTIONS IN COLON CANCER PATIENTS WITH SYNCHRONOUS LIVER METASTASES: PROGNOSTIC IMPACT OF LYMPH NODE RATIO AND TUMOR BURDEN SCORE.
- 30 Dec 2025
- Experimental oncology
LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY.
- 30 Dec 2025
- Experimental oncology
Title not available
- 30 Dec 2025
- Experimental Oncology
UTILIZING INFRARED IMAGING TO EVALUATE THE AGGRESSIVENESS OF PROSTATE CANCER.
- 30 Dec 2025
- Experimental oncology
RADIOFREQUENCY ABLATION AS PART OF INTRAHEPATIC TREATMENT STRATEGIES.
- 30 Dec 2025
- Experimental oncology
ASSOCIATION OF INTRON 4 VNTR (4A/B) POLYMORPHISM OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE WITH THE INCIDENCE OF BREAST CANCER IN IRAQI WOMEN.
- 30 Dec 2025
- Experimental oncology
SIMULTANEOUS VS STAGED RESECTIONS IN COLON CANCER PATIENTS WITH SYNCHRONOUS LIVER METASTASES: PROGNOSTIC IMPACT OF LYMPH NODE RATIO AND TUMOR BURDEN SCORE.
- 30 Dec 2025
- Experimental oncology
LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY.
- 30 Dec 2025
- Experimental oncology